EE+ POEM Archive
Baloxavir reduces symptom duration similarly to oseltamivir, primarily within 24 hours of symptom onset
Baloxavir reduces symptom duration similarly to oseltamivir, primarily within 24 hours of symptom onset is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
Slawson, David C., et al., editors. "Baloxavir Reduces Symptom Duration Similarly to Oseltamivir, Primarily Within 24 Hours of Symptom Onset." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314832/all/Baloxavir_reduces_symptom_duration_similarly_to_oseltamivir__primarily_within_24_hours_of_symptom_onset.
Baloxavir reduces symptom duration similarly to oseltamivir, primarily within 24 hours of symptom onset. In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314832/all/Baloxavir_reduces_symptom_duration_similarly_to_oseltamivir__primarily_within_24_hours_of_symptom_onset. Accessed January 16, 2021.
Baloxavir reduces symptom duration similarly to oseltamivir, primarily within 24 hours of symptom onset. (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. John Wiley & Sons. Retrieved January 16, 2021, from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314832/all/Baloxavir_reduces_symptom_duration_similarly_to_oseltamivir__primarily_within_24_hours_of_symptom_onset
Baloxavir Reduces Symptom Duration Similarly to Oseltamivir, Primarily Within 24 Hours of Symptom Onset [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2021 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314832/all/Baloxavir_reduces_symptom_duration_similarly_to_oseltamivir__primarily_within_24_hours_of_symptom_onset.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Baloxavir reduces symptom duration similarly to oseltamivir, primarily within 24 hours of symptom onset
ID - 1314832
ED - Slawson,David C,
ED - Shaughnessy,Allen F,
ED - Ebell,Mark H,
ED - Barry,Henry,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314832/all/Baloxavir_reduces_symptom_duration_similarly_to_oseltamivir__primarily_within_24_hours_of_symptom_onset
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
